info:eu-repo/semantics/article
Galectin-3 deficiency drives lupus-like disease by promoting spontaneous germinal centers formation via IFN-γ
Fecha
2018-12Registro en:
Beccaria, Cristian Gabriel; Amezcua Vesely, Maria Carolina; Fiocca Vernengo, Facundo; Gehrau, Ricardo Carlos; Ramello, María Cecilia; et al.; Galectin-3 deficiency drives lupus-like disease by promoting spontaneous germinal centers formation via IFN-γ; Nature Publishing Group; Nature Communications; 9; 1; 12-2018; 1-15
2041-1723
CONICET Digital
CONICET
Autor
Beccaria, Cristian Gabriel
Amezcua Vesely, Maria Carolina
Fiocca Vernengo, Facundo
Gehrau, Ricardo Carlos
Ramello, María Cecilia
Tosello Boari, Jimena
Gorosito Serran, Melisa
Mucci, Juan Sebastián
Piaggio, Eliane
Campetella, Oscar Eduardo
Acosta Rodriguez, Eva Virginia
Montes, Carolina Lucia
Gruppi, Adriana
Resumen
Germinal centers (GC) are important sites for high-affinity and long-lived antibody induction. Tight regulation of GC responses is critical for maintaining self-tolerance. Here, we show that Galectin-3 (Gal-3) is involved in GC development. Compared with WT mice, Gal-3 KO mice have more GC B cells and T follicular helper cells, increased percentages of antibody-secreting cells and higher concentrations of immunoglobulins and IFN-γ in serum, and develop a lupus-like disease. IFN-γ blockade in Gal-3 KO mice reduces spontaneous GC formation, class-switch recombination, autoantibody production and renal pathology, demonstrating that IFN-γ overproduction sustains autoimmunity. The results from chimeric mice show that intrinsic Gal-3 signaling in B cells controls spontaneous GC formation. Taken together, our data provide evidence that Gal-3 acts directly on B cells to regulate GC responses via IFN-γ and implicate the potential of Gal-3 as a therapeutic target in autoimmunity.